Next Article in Journal
Vascular Calcification Is Associated with Fetuin-A and Cortical Bone Porosity in Stone Formers
Next Article in Special Issue
Dendrimers, an Emerging Opportunity in Personalized Medicine?
Previous Article in Journal
A Possible Link between Gut Microbiome Composition and Cardiovascular Comorbidities in Psoriatic Patients
Previous Article in Special Issue
Individualized 3D-Printed Bone-Anchored Maxillary Protraction Device for Growth Modification in Skeletal Class III Malocclusion
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 12
Issue 7
10.3390/jpm12071119
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality?

by
Ishika Mahajan
1,
Aruni Ghose
2,3,4,5,
Deepika Gupta
6,
Manasi Manasvi
7,
Saisha Bhandari
8,
Aparimita Das
9,
Elisabet Sanchez
4 and
Stergios Boussios
4,10,11,*
1
Department of Medical Oncology, Apollo Cancer Centre, Chennai 600001, India
2
Department of Medical Oncology, Barts Cancer Centre, St. Bartholomew’s Hospital, Barts Health NHS Trust, London KT1 2EE, UK
3
Department of Medical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, London KT1 2EE, UK
4
Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, UK
5
Division of Research, Academics and Cancer Control, Saroj Gupta Cancer Centre and Research Institute, Kolkata 700001, India
6
Microbiology, College of Medicine and Sagore Dutta Hospital, Kolkata 700001, India
7
Internal Medicine, Kasturba Medical College, Mangalore 574142, India
8
Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh 133301, India
9
Faculty of Allied Health Sciences, Chettinad Academy of Research and Education, Chennai 600001, India
10
Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, King’s College London, London SE1 9RT, UK
11
AELIA Organization, 9th Km Thessaloniki-Thermi, 57001 Thessaloniki, Greece
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2022, 12(7), 1119; https://doi.org/10.3390/jpm12071119
Submission received: 16 June 2022 / Revised: 4 July 2022 / Accepted: 8 July 2022 / Published: 10 July 2022
(This article belongs to the Special Issue Personalized and Precision Medicine 2022)
Browse Figure
Review Reports Versions Notes

Abstract

COVID-19 has been responsible for widespread morbidity and mortality worldwide. Invasive mucormycosis has death rates scaling 80%. India, one of the countries hit worst by the pandemic, is also a hotbed with the highest death rates for mucormycosis. Cancer, a ubiquitously present menace, also contributes to higher case fatality rates. All three entities studied here are individual, massive healthcare threats. The danger of one disease predisposing to the other, the poor performance status of patients with all three diseases, the impact of therapeutics for one disease on the pathology and therapy of the others all warrant physicians having a better understanding of the interplay. This is imperative so as to effectively establish control over the individual patient and population health. It is important to understand the interactions to effectively manage all three entities together to reduce overall morbidity. In this review article, we search for an inter-relationship between the COVID-19 pandemic, emerging mucormycosis, and the global giant, cancer.
Keywords: cancer; mucormycosis; COVID-19; COVID-associated mucormycosis; diabetes; steroids; immunosuppression cancer; mucormycosis; COVID-19; COVID-associated mucormycosis; diabetes; steroids; immunosuppression

Share and Cite

MDPI and ACS Style

Mahajan, I.; Ghose, A.; Gupta, D.; Manasvi, M.; Bhandari, S.; Das, A.; Sanchez, E.; Boussios, S. COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality? J. Pers. Med. 2022, 12, 1119. https://doi.org/10.3390/jpm12071119

AMA Style

Mahajan I, Ghose A, Gupta D, Manasvi M, Bhandari S, Das A, Sanchez E, Boussios S. COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality? Journal of Personalized Medicine. 2022; 12(7):1119. https://doi.org/10.3390/jpm12071119

Chicago/Turabian Style

Mahajan, Ishika, Aruni Ghose, Deepika Gupta, Manasi Manasvi, Saisha Bhandari, Aparimita Das, Elisabet Sanchez, and Stergios Boussios. 2022. "COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality?" Journal of Personalized Medicine 12, no. 7: 1119. https://doi.org/10.3390/jpm12071119

APA Style

Mahajan, I., Ghose, A., Gupta, D., Manasvi, M., Bhandari, S., Das, A., Sanchez, E., & Boussios, S. (2022). COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality? Journal of Personalized Medicine, 12(7), 1119. https://doi.org/10.3390/jpm12071119

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop